• Plumas Bancorp (NASDAQ:PLBC) exceeds earnings and revenue expectations, showcasing strong financial health.
• The company reported an EPS of $1.56, surpassing the estimated $1.37, and a revenue of $28.21 million, beating the anticipated $27.11 million.
• PLBC demonstrates a solid market valuation with a P/E ratio of approximately 11.77 and an earnings yield of about 8.49%.

Plumas Bancorp (NASDAQ:PLBC) is a financial institution operating in the Zacks Banks - West industry. The company provides a range of banking services, including loans and deposit products. It competes with other regional banks in the western United States. PLBC's recent financial performance has been noteworthy, with the company consistently surpassing earnings and revenue expectations.

On January 21, 2026, PLBC reported earnings per share (EPS) of $1.56, exceeding the estimated $1.37. This represents a 13.87% earnings surprise, as highlighted by Zacks. The company has a history of outperforming expectations, having exceeded consensus EPS estimates in three of the past four quarters. In the previous quarter, PLBC reported an EPS of $1.35, significantly higher than the anticipated $0.66, resulting in a 104.55% surprise.

PLBC's revenue for the quarter was $28.21 million, surpassing the anticipated $27.11 million. This is a 3.73% increase over the Zacks Consensus Estimate. Compared to the same quarter last year, when revenue was $21.16 million, this marks a substantial growth. The company has outperformed consensus revenue estimates twice in the last four quarters, demonstrating its ability to generate strong sales.

The company's financial metrics provide further insight into its performance. PLBC has a price-to-earnings (P/E) ratio of approximately 11.77, indicating how the market values its earnings. The price-to-sales ratio is about 3.38, reflecting the company's market value relative to its sales. Additionally, the enterprise value to sales ratio is around 3.95, suggesting the company's total value compared to its sales.

PLBC's financial health is also evident in its earnings yield of about 8.49%, which indicates the return on investment for shareholders. The debt-to-equity ratio is approximately 0.59, showing a balanced use of debt and equity to finance its assets. However, the current ratio of around 0.28 suggests a need for improvement in covering short-term liabilities with short-term assets.